We are live on ! Find out more
EVH icon

Evolent Health

110 hedge funds and large institutions have $672M invested in Evolent Health in 2016 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

750% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 4

150% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 18

94% more capital invested

Capital invested by funds: $347M → $672M (+$325M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

38% more funds holding

Funds holding: 80110 (+30)

16.82% more ownership

Funds ownership: 42.43%59.24% (+17%)

4% less call options, than puts

Call options by funds: $596K | Put options by funds: $620K

Holders
110
Holders Change
+30
Holders Change %
+37.5%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
34
Increased
45
Reduced
18
Closed
4
Calls
$596K
Puts
$620K
Net Calls
-$24K
Net Calls Change
-$14K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$6.34M +$6.02M +257,522 New
PC
27
Pier Capital
Connecticut
$5.89M +$5.59M +239,223 New
State Street
28
State Street
Massachusetts
$5.85M +$664K +28,425 +14%
MIM
29
Monashee Investment Management
Massachusetts
$5.55M
Invesco
30
Invesco
Georgia
$5.48M +$5.2M +222,514 New
WSA
31
Wall Street Associates
California
$5.09M +$701K +30,000 +17%
USAA
32
United Services Automobile Association
Texas
$4.85M +$1.53M +65,350 +50%
PAM
33
Panagora Asset Management
Massachusetts
$4.55M +$4.32M +184,999 New
Northern Trust
34
Northern Trust
Illinois
$4.35M +$365K +15,593 +10%
SFM
35
Systematic Financial Management
New Jersey
$4.21M -$242K -10,355 -6%
Deutsche Bank
36
Deutsche Bank
Germany
$4.07M +$1.42M +60,879 +58%
Two Sigma Investments
37
Two Sigma Investments
New York
$3.98M +$3.78M +161,654 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$3.97M -$48.5K -2,075 -1%
American Century Companies
39
American Century Companies
Missouri
$3.95M -$2.87M -122,693 -43%
DCM
40
Driehaus Capital Management
Illinois
$3.94M -$176K -7,530 -4%
Renaissance Technologies
41
Renaissance Technologies
New York
$3.62M +$3.43M +146,900 New
Lord, Abbett & Co
42
Lord, Abbett & Co
New Jersey
$2.94M -$2.81M -120,340 -50%
Geode Capital Management
43
Geode Capital Management
Massachusetts
$2.88M +$646K +27,622 +31%
Millennium Management
44
Millennium Management
New York
$2.8M -$835K -35,714 -24%
LCM
45
Laurion Capital Management
New York
$2.77M +$2.63M +112,500 New
Macquarie Group
46
Macquarie Group
Australia
$2.35M -$2.69M -115,027 -55%
EA
47
Emerald Acquisition
Washington
$2.18M +$482K +20,613 +30%
Marshall Wace
48
Marshall Wace
United Kingdom
$1.97M +$1.87M +80,099 New
Two Sigma Advisers
49
Two Sigma Advisers
New York
$1.67M +$1.59M +67,900 New
BIM
50
BlackRock Investment Management
Delaware
$1.57M -$6.92K -296 -0.5%

EVH Hedge Fund Activity: Q3 2016 in Review

110 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2016, worth a combined $672M — up 94% from $347M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new EVH positions and 4 closed out — a net gain of 30 holders — while 45 added to existing stakes and 18 trimmed.

The largest buyer was Capital World Investors, adding an estimated $28.3M. The largest seller was Wells Fargo, cutting an estimated $24.7M.

  • 110 institutional investors held Evolent Health (EVH) as of Q3 2016, up from 80 in Q2 2016.
  • Funds reported $672M of Evolent Health stock for Q3 2016, up 94% quarter-over-quarter.
  • 34 funds opened new Evolent Health positions in Q3 2016 and 4 closed out, a net change of +30 holders.
  • The largest Evolent Health buyer in Q3 2016 was Capital World Investors, an estimated $28.3M added.
  • The largest Evolent Health seller in Q3 2016 was Wells Fargo, an estimated $24.7M sold.

Based on aggregated 13F filings for Q3 2016.